Are you affected by the LRQA announcement?
The LRQA has given 90 days’ notice that it will withdraw from its notified body (NB) services under the EU’s current medical device and in vitro diagnostic directives and will not apply to be an NB under the new medical device and in vitro diagnostic regulations (MDR/IVDR). They have directed their clients to choose an alternative NB.
Medilink has expressed its concerns on this matter to various government agencies, as there is already a serious under capacity within UK notified bodies, and this announcement will create major problems for member companies using LRQA.
We need to know the extent of this problem and would ask that member companies accredited by LRQA or in the process of being accredited by LRQA, contact us to let us know the size and nature of the problems you face. Contact email@example.com or call 0114 232 9292.